Literature DB >> 31648510

[Eradication of Achromobacter spp. multiresistente with colistin otic in patient with chronic otitis media suppurated].

A Trujillano Ruiz1, J Giménez Castellanos, J F Andreo Marroig, J Mesquida Riera, V Cano Collado.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31648510      PMCID： PMC6913077     

Source DB:  PubMed          Journal:  Rev Esp Quimioter        ISSN： 0214-3429            Impact factor:   1.553


× No keyword cloud information.
  6 in total

Review 1.  Chronic suppurative otitis media: a review.

Authors:  Monique Verhoeff; Erwin L van der Veen; Maroeska M Rovers; Elisabeth A M Sanders; Anne G M Schilder
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2005-09-27       Impact factor: 1.675

2.  Achromobacter xylosoxidans n. sp. from human ear discharge.

Authors:  E Yabuuchi; A Oyama
Journal:  Jpn J Microbiol       Date:  1971-09

3.  Complicated intra-abdominal infection caused by extended drug-resistant Achromobacter xylosoxidans.

Authors:  Sing-On Teng; Tsong-Yih Ou; Yu-Chia Hsieh; Wuan-Chan Lee; Yi-Chun Lin; Wen-Sen Lee
Journal:  J Microbiol Immunol Infect       Date:  2009-04       Impact factor: 4.399

4.  Early treatment with inhaled antibiotics postpones next occurrence of Achromobacter in cystic fibrosis.

Authors:  M Wang; W Ridderberg; C R Hansen; N Høiby; S Jensen-Fangel; H V Olesen; M Skov; L E Lemming; T Pressler; H K Johansen; N Nørskov-Lauritsen
Journal:  J Cyst Fibros       Date:  2013-05-31       Impact factor: 5.482

5.  Achromobacter xylosoxidans is the predominant Achromobacter species isolated from diverse non-respiratory samples.

Authors:  L Amoureux; J Bador; T Verrier; H Mjahed; C DE Curraize; C Neuwirth
Journal:  Epidemiol Infect       Date:  2016-08-18       Impact factor: 4.434

Review 6.  Understanding the aetiology and resolution of chronic otitis media from animal and human studies.

Authors:  Mahmood F Bhutta; Ruth B Thornton; Lea-Ann S Kirkham; Joseph E Kerschner; Michael T Cheeseman
Journal:  Dis Model Mech       Date:  2017-11-01       Impact factor: 5.758
  6 in total
  1 in total

Review 1.  Achromobacter Infections and Treatment Options.

Authors:  Burcu Isler; Timothy J Kidd; Adam G Stewart; Patrick Harris; David L Paterson
Journal:  Antimicrob Agents Chemother       Date:  2020-10-20       Impact factor: 5.191
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.